You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -13.6% | 51.9% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -57.0 | 478.5 |
| PEG | 0.0 | -0.1 |
| Price / Revenue | 24.6 | 1.6 |
| Price / Book value | 22.1 |
| Latest | Forecast | |
|---|---|---|
| Revenue | -4.7% | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (€m) |
Pre-tax (€m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | 11.08 | -5.71 | €-0.47 | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2017-12-31 | 12.75 | -3.49 | €-0.15 | -4.4 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | 13.72 | -2.08 | €-0.06 | -6.2 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | 13.08 | -3.91 | €-0.08 | -1.9 | 0.0 | n/a | n/a | 0.0% |
| Novacyt dispute with DHSC to dent 2021 profit, shares slide Sharecast News | 09 Apr |
|---|---|
| Novacyt launches CE-marked rapid Covid-19 variant test Sharecast News | 24 Mar |
| Novacyt launches mobile Covid-19 testing labs Sharecast News | 17 Mar |
| Trading Update | 09-Apr-21 12:30 |
|---|---|
| Total Voting Rights | 01-Apr-21 13:40 |
| Launch of VariPLEX CE-Mark test | 24-Mar-21 07:00 |
| Launch of mobile processing laboratories | 17-Mar-21 07:12 |
| Holdings in Company | 15-Mar-21 16:45 |